We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Complete Genomics DNA Mapping Costs Slashed

By LabMedica International staff writers
Posted on 20 Jan 2009
An American biotech company has reported that by 2009 it will be able to map the complete human genome for just US$5,000--a very significant reduction in price from the $100,000 to $350,000 currently priced by other companies.

The company announcing the new pricing on their product is Complete Genomics (Mountain View, CA, USA). Whereas other companies now offer testing for between $399 and $1,000, those tests are just a topical look into an individual's complete DNA profile. Determining the genetic code is seen as the answer to helping solve mysteries about human disorders, many of which have a genetic basis. "The ability to compare a significant number of genomes of people with a disease against those without the disease is central to enabling drug discovery and the development of new diagnostics,” explained Harvard University (Cambridge, MA, USA) geneticist and Complete Genomics' board member George Church, a member of Complete Genomics' scientific advisory board.

The company will not be targeting the consumer market. Instead, it will sell its technology to pharmaceutical companies, researchers, and businesses that provide genetic testing, such as the biotech company Knome (Cambridge, MA, USA). Knome, which now offers consumers complete genome sequencing for $350,000, reported that it might negotiate with Complete Genomics about adopting its technology for the public market.

Related Links:

Complete Genomics
Knome



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
Repetitive Pipette
VWR® Stepper Pro
Chromogenic Culture System
InTray™ COLOREX™ ECC

Latest BioResearch News

Study Reveals New Insights into Rare Blood Cancer Development
20 Jan 2009  |   BioResearch

New Findings Clarify Molecular Drivers of Rare Small Intestinal Cancer
20 Jan 2009  |   BioResearch

Lung Cancer Study Reveals Cellular Program Behind Therapy Resistance
20 Jan 2009  |   BioResearch



ADLM